
Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.
New tool predicts low-risk betalactam allergies with 93% specificity! 🤖📊 Study on 6468 patients shows promise for delabeling.







